| ASSET | YEAR | % RETURN |
|---|---|---|
CareDx (CDNA) | 2018 | 240.19% |
Arrowhead Pharmaceuticals (ARWR) | 2018 | 236.59% |
Vericel Corp Ord (VCEL) | 2018 | 213.51% |
Trade Desk (TTD) | 2018 | 154.02% |
Xenon Pharmaceuticals (XENE) | 2018 | 125.36% |
Glaukos (GKOS) | 2018 | 116.87% |
Krystal Biotech (KRYS) | 2018 | 107.8% |
Acm Research (ACMR) | 2018 | 107.24% |
Crocs (CROX) | 2018 | 105.54% |
PTC Therapeutics (PTCT) | 2018 | 103.56% |
Magnite (MGNI) | 2018 | 99.47% |
Enphase Energy (ENPH) | 2018 | 97.91% |
Addus HomeCare (ADUS) | 2018 | 94.5% |
Veracyte (VCYT) | 2018 | 92.06% |
Viking Therapeutics (VKTX) | 2018 | 87.04% |
Wingstop (WING) | 2018 | 84.9% |
Applied Digital (APLD) | 2018 | 83.33% |
OFG Bancorp (OFG) | 2018 | 78.29% |
HCI (HCI) | 2018 | 75.75% |
Companhia Energetica de Minas Gerais CEMIG Pref ADR (CIG) | 2018 | 75.51% |
Five9 (FIVN) | 2018 | 75.23% |
Liquidia Technologies (LQDA) | 2018 | 73.98% |
SPS Commerce (SPSC) | 2018 | 69.19% |
Ringcentral (RNG) | 2018 | 68.93% |
Freshpet (FRPT) | 2018 | 68.38% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.